Skip to main content

Table 4 CNV region associated with NAFLD

From: Identifying potential biomarkers of nonalcoholic fatty liver disease via genome-wide analysis of copy number variation

Region

Gene

Sample frequency (gains, losses)

Function

GO item

Relevant study ( DOI)

Chr3:57199594-57590187

APPL1

1 (0, 1)

Adiponectin, insulin signalling

GO:0008286

10.1371/journal.pone.0071391

Chr7:54813380-55274871

EGFR

1 (0, 1)

Tyrosine phosphorylation regulates cell proliferation

GO:0000165

10.3969/j.issn.1674-4136.2017.05.016; 10.1016/j.bbadis.2017.10.016

Chr17:38688567-38738474

CCR7

2 (0, 2)

Participates inflammatory response

GO:0007249

10.1038/ijo.2017.200; 10.3870/j.issn.1672-0741.2017.06.011

Chr19:56370486-56416408

NLRP4

3 (0, 3)

Inhibition of type I interferon and NF-KB inflammatory signalling

GO:0032479

10.1186/s12876-014-0208-8; 10.1074/jbc.M200446200

Chr22:24347959-24390254

GSTT1

7 (6, 1)

Participates in the phase II reaction and promote toxic metabolism

GO:0004602

10.1016/j.clinre.2011.01.015

Chr14:74001651-74022324

ACOT1

2 (1, 1)

Regulation of lipid metabolism enzyme activity

GO:0071616

10.2337/db16-1519; 10.1194/jlr.M081455

Chr12:57897795-57918452

CHOP

1 (1, 0)

Participates in endoplasmic reticulum stress and promote apoptosis

GO:0036488

10.1038/labinvest.2016.61; 10.1016/j.ejps.2011.02.005

Chr1:65935075-65959904

LEPR

1 (0, 1)

Regulates leptin signalling

GO:0038021

10.2174/1566524018666180705110412; 10.3870/lcxh.j.issn.1005-541X.2011.03.07

Chr20:33470663-33495348

ACSS2

1 (0, 1)

Regulation of lipid metabolism enzyme activity

GO:0006085

10.1073/pnas.1806635115; 10.1002/jcp.25954